Underneath the Arches, no. 61, October 24, 1968

Underneath the Arches was Grand Valley State\u27s faculty and staff newsletter, published from 1963 to 1971. It was a precursor to the Forum

Log-Rank-Test FoxP3+.

<p>Peripheral accumulation of FoxP3+ Cells leads to reduced survival (p = 0.056).</p

Survival analysis for ß-Catenin.

<p>Survival analysis for ß-Catenin. Survival was better for the subgroup of patients with ß-Catenin n-m+ tumors (N = 64) compared to the subgroup ß-Catenin n-m- (N = 28) and ß-Catenin n+m+ tumors (N = 5).</p

Scoring System.

<p>Scoring System.</p

Survival analysis for p53.

<p>Survival was better for the subgroup of patients with p53 positive tumors (N = 61) compared to the subgroup with p53 negative/overexpression tumors (N = 36).</p

CD8+ T-cells: Tumor infiltration pattern.

<p>CD8+ T-cells: Tumor infiltration pattern.</p

FoxP3+ cells: Location.

<p>FoxP3+ cells: Location.</p

Correlation among ARID1A/ß-Catenin and ß-Catenin/p16 in endometrioid and clear cell ovarian and uterine tissues.

<p>Correlation among ARID1A/ß-Catenin and ß-Catenin/p16 in endometrioid and clear cell ovarian and uterine tissues.</p

The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium - Fig 1

<p><b>Immunohistochemical stainings for ß-Catenin, p53, ARID1A, p16 and p21 in clear-cell (A and B) and endometrioid (C—K) carcinomas</b>. Focal, very weak membranous (n-m-) (A), membranous (n-m+) (B) and nuclear (n+m+) (C) expression of β-catenin. Regulated (D) and aberrant (E) expression of p53. Preserved expression of ARID1A (F) and loss (G) of ARID1A expression. Negative staining (H) and positive (I) staining for p16. Negative (J) and positive staining (K) of p21. 400 × magnification was used for all pictures; scale bar (K) refers to 60 μm for all images.</p